Proteomic analysis of Alzheimer’s disease cerebrospinal fluid reveals alterations associated with APOE ε4 and atomoxetine treatment is a research paper published in Science Translational Medicine (2024). On theSindex it has a DataRank of 0.606. It has been cited 56 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.606
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIA NIH HHS
Grant: R01 AG070937
NIA NIH HHS
Grant: R01 AG065596
NIA NIH HHS
Grant: U01 AG046161
NHLBI NIH HHS
Grant: U01 HL096812
NHLBI NIH HHS
Grant: U01 HL096899
NHLBI NIH HHS
Grant: U01 HL096917
NIA NIH HHS
Grant: K08 AG068604
NIA NIH HHS
Grant: R01 AG072120
NIA NIH HHS
Grant: U01 AG061357
NIA NIH HHS
Grant: R01 AG075827
NHLBI NIH HHS
Grant: U01 HL096814
NIA NIH HHS
Grant: P30 AG066511
FWCI
13.15
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals